Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: A randomized controlled trial

David Johnson, Carmel Hawley, Brenda Rosser, Elaine Beller, Charles Thompson, Robert Fassett, Paolo Ferrari, Stephen MacDonald, Eugenie Pedagogos, Alan Cass

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalBMC Nephrology
Volume9
Issue number1
Publication statusPublished - 2008
Externally publishedYes

Cite this

Johnson, D., Hawley, C., Rosser, B., Beller, E., Thompson, C., Fassett, R., Ferrari, P., MacDonald, S., Pedagogos, E., & Cass, A. (2008). Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: A randomized controlled trial. BMC Nephrology, 9(1), 1-7.